Group One Trading
PCVX icon

Group One Trading’s Vaxcyte PCVX Stock Holding History

Group One Trading’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$755K Buy
+13,000
New +$706K ﹤0.01% 2958
2025
Q4 		– Sell
-100,500
Closed -$3.62M – 8898
2025
Q3 		$3.62M Sell
100,500
-13,900
-12% -$461K 0.01% 1774
2025
Q2 		$3.72M Buy
114,400
+106,800
+1,405% +$3.5M 0.01% 1567
2025
Q1 		$287K Sell
7,600
-7,000
-48% -$560K ﹤0.01% 3654
2024
Q4 		$1.2M Sell
14,600
-1,200
-8% -$119K ﹤0.01% 2399
2024
Q3 		$1.81M Buy
15,800
+15,700
+15,700% +$1.41M 0.01% 1793
2024
Q2 		$7.55K Sell
100
-24,000
-100% -$1.63M ﹤0.01% 5765
2024
Q1 		$1.65M Buy
24,100
+9,400
+64% +$651K 0.01% 1645
2023
Q4 		$923K Buy
14,700
+10,300
+234% +$535K ﹤0.01% 2527
2023
Q3 		$224K Buy
4,400
+600
+16% +$29.6K ﹤0.01% 3702
2023
Q2 		$190K Sell
3,800
-2,000
-34% -$94.8K ﹤0.01% 3988
2023
Q1 		$217K Sell
5,800
-28,400
-83% -$1.2M ﹤0.01% 3590
2022
Q4 		$1.64M Buy
+34,200
New +$1.34M ﹤0.01% 1998

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Group One Trading's PCVX Position: Q1 2026 in Review

Group One Trading sold out of Vaxcyte (PCVX) in Q1 2026, closing a stake of 831 shares — an estimated $45.1K sold.

Group One Trading first reported a position in PCVX in Q2 2024 and held it in 3 quarters. The position peaked at $350K in Q4 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Group One Trading reported no remaining Vaxcyte position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 831 Vaxcyte shares in Q1 2026, an estimated $45.1K.
  • Group One Trading first reported a position in Vaxcyte in Q2 2024 and held it in 3 quarters.
  • Group One Trading's Vaxcyte position peaked at $350K in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.